Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Assa

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|May 9, 2023
Drugs in Focus: DomperidoneMaria Giovanna Puoti, Amit Assa, Marc Benninga, et al.
The Lancet. Gastroenterology & Hepatology|January 9, 2025
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort studyOhad Atia, Zivia Shavit-Brunschwig, Raffi Lev-Tzion, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 22, 2023
Pediatric Magnet Ingestion, Diagnosis, Management, and Prevention: A European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) Position PaperA A Nugud, Christos Tzivinikos, Amit Assa, et al.
Inflammatory Bowel Diseases|June 13, 2025
Safety and Effectiveness of QingDai (Indigo naturalis) in Children With Mild-to-Moderate Ulcerative Colitis: A Short-Term 6-Week Open-Label TrialDotan Yogev, Yael Weintraub, Oren Ledder, et al.
Frontiers in Pediatrics|September 19, 2022
Immune function in newborns with <i>in-utero</i> exposure to anti-TNFα therapyBatia Weiss, Shomron Ben-Horin, Atar Lev, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2014
Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumabHenit Yanai, Lev Lichtenstein, Amit Assa, et al.
Inflammatory Bowel Diseases|November 6, 2019
Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHANMassimo Martinelli, Francesca Paola Giugliano, Caterina Strisciuglio, et al.
Crohn'S & Colitis 360|February 13, 2023
Development and Validation of the IBD-REFER Criteria: Early Referral for Suspected Inflammatory Bowel Diseases in Adults and ChildrenOhad Atia, Adi Shosberger, Gili Focht, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 1, 2017
Perianal Pediatric Crohn Disease Is Associated With a Distinct Phenotype and Greater Inflammatory BurdenAmit Assa, Michal Amitai, Mary-Louise Greer, et al.
Digestive Diseases and Sciences|November 28, 2024
Serological Markers as Predictors of Anti-TNF Response in Children with Crohn's DiseaseYaara Lisai-Goldstein, Gili Focht, Esther Orlanski-Meyer, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
Journal of Pediatric Gastroenterology and Nutrition|May 9, 2023
Drugs in Focus: DomperidoneMaria Giovanna Puoti, Amit Assa, Marc Benninga, et al.
The Lancet. Gastroenterology & Hepatology|January 9, 2025
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort studyOhad Atia, Zivia Shavit-Brunschwig, Raffi Lev-Tzion, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 22, 2023
Pediatric Magnet Ingestion, Diagnosis, Management, and Prevention: A European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) Position PaperA A Nugud, Christos Tzivinikos, Amit Assa, et al.
Inflammatory Bowel Diseases|June 13, 2025
Safety and Effectiveness of QingDai (Indigo naturalis) in Children With Mild-to-Moderate Ulcerative Colitis: A Short-Term 6-Week Open-Label TrialDotan Yogev, Yael Weintraub, Oren Ledder, et al.
Frontiers in Pediatrics|September 19, 2022
Immune function in newborns with <i>in-utero</i> exposure to anti-TNFα therapyBatia Weiss, Shomron Ben-Horin, Atar Lev, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2014
Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumabHenit Yanai, Lev Lichtenstein, Amit Assa, et al.
Inflammatory Bowel Diseases|November 6, 2019
Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHANMassimo Martinelli, Francesca Paola Giugliano, Caterina Strisciuglio, et al.
Crohn'S & Colitis 360|February 13, 2023
Development and Validation of the IBD-REFER Criteria: Early Referral for Suspected Inflammatory Bowel Diseases in Adults and ChildrenOhad Atia, Adi Shosberger, Gili Focht, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 1, 2017
Perianal Pediatric Crohn Disease Is Associated With a Distinct Phenotype and Greater Inflammatory BurdenAmit Assa, Michal Amitai, Mary-Louise Greer, et al.
Digestive Diseases and Sciences|November 28, 2024
Serological Markers as Predictors of Anti-TNF Response in Children with Crohn's DiseaseYaara Lisai-Goldstein, Gili Focht, Esther Orlanski-Meyer, et al.
Pageof 16